TICKERNOMICS Sign up
Last Update: 2024-12-27 15:25:16
Axogen Inc. ( AXGN ) https://www.axogeninc.com
16.73USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
AXGN
143.17%
SPY
32.66%
AXGN
79.51%
SPY
108.59%
-10.05%
AXGN
SPY
302.52%
AXGN
363.43%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
734.15
764.61
0.50
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-51.31
4.06
7.39
-1.41
0.00
603.01
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-0.65
74.91
0.68
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
9.3616
-11.69
-3.33
1.37
Other Earnings and Cash Flow Stats:
Axogen Inc. ( AXGN ) Net Income TTM ($MM) is -14.31
Axogen Inc. ( AXGN ) Operating Income TTM ($MM) is -8.50
Axogen Inc. ( AXGN ) Owners' Earnings Annual ($MM) is 0.00
Axogen Inc. ( AXGN ) Current Price to Owners' Earnings ratio is 0.00
Axogen Inc. ( AXGN ) EBITDA TTM ($MM) is -1.41
Axogen Inc. ( AXGN ) EBITDA Margin is 0.68%
Capital Allocation:
Axogen Inc. ( AXGN ) has paid 0.00 dividends per share and bought back -0.859782 million shares in the past 12 months
Axogen Inc. ( AXGN ) has reduced its debt by 19.369 million USD in the last 12 months
Capital Structure:
Axogen Inc. ( AXGN ) Interest-bearing Debt ($MM) as of last quarter is 49
Axogen Inc. ( AXGN ) Annual Working Capital Investments ($MM) are 5
Axogen Inc. ( AXGN ) Book Value ($MM) as of last quarter is 99
Axogen Inc. ( AXGN ) Debt/Capital as of last quarter is 49%
Other Balance Sheet Stats:
Axogen Inc. ( AXGN ) has 18 million in cash on hand as of last quarter
Axogen Inc. ( AXGN ) has 23 million of liabilities due within 12 months, and long term debt 47 as of last quarter
Axogen Inc. ( AXGN ) has 43 common shares outstanding as of last quarter
Axogen Inc. ( AXGN ) has 0 million USD of preferred stock value
Academic Scores:
Axogen Inc. ( AXGN ) Altman Z-Score is 3.90 as of last quarter
Axogen Inc. ( AXGN ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
Axogen Inc. ( AXGN ) largest shareholder is owning shares at 0.00 ($MM) value
Zaderej Karen L.(an insider) Sold 3166 shares of Axogen Inc. ( AXGN ) for the amount of $24314.88 on 2024-03-21
5.55% of Axogen Inc. ( AXGN ) is held by insiders, and 80.40% is held by institutions
Axogen Inc. ( AXGN ) went public on 1990-03-27
Other Axogen Inc. ( AXGN ) financial metrics:
FCF:-8.49
Unlevered Free Cash Flow:0.00
EPS:-0.17
Operating Margin:-0.65
Gross Profit Margin:74.91
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-7.48
Beta:1.37
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Axogen Inc. ( AXGN ) :
AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.